Cargando…
Molecular Bases for the Regulation of NKG2D Ligands in Cancer
NKG2D is an activating receptor expressed by NK and T cells primarily involved in the elimination of transformed and infected cells. NKG2D ligands are self-proteins restrictedly expressed in healthy tissues, but induced in response to signaling pathways commonly associated with transformation. Proli...
Autores principales: | Huergo-Zapico, Leticia, Acebes-Huerta, Andrea, López-Soto, Alejandro, Villa-Álvarez, Mónica, Gonzalez-Rodriguez, Ana Pilar, Gonzalez, Segundo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968767/ https://www.ncbi.nlm.nih.gov/pubmed/24711808 http://dx.doi.org/10.3389/fimmu.2014.00106 |
Ejemplares similares
-
Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition
por: López-Soto, Alejandro, et al.
Publicado: (2013) -
Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
por: Huergo-Zapico, Leticia, et al.
Publicado: (2014) -
Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)
por: Fernández-Guizán, Azahara, et al.
Publicado: (2015) -
Lenalidomide and Chronic Lymphocytic Leukemia
por: González-Rodríguez, Ana Pilar, et al.
Publicado: (2013) -
Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
por: Acebes-Huerta, Andrea, et al.
Publicado: (2014)